| Literature DB >> 25808062 |
D T T Huynh1, E Estorninos2, R Z Capeding2, J S Oliver3, Y L Low1, F J Rosales3.
Abstract
BACKGROUND: The benefits of short-term oral nutritional supplementation (ONS) in undernourished children are well-established. The benefits of long-term ONS in promoting longitudinal growth and health in children who are at risk of undernutrition have not been reported previously.Entities:
Keywords: long-term supplementation; longitudinal growth; oral nutritional supplement; undernutrition
Mesh:
Year: 2015 PMID: 25808062 PMCID: PMC6680231 DOI: 10.1111/jhn.12306
Source DB: PubMed Journal: J Hum Nutr Diet ISSN: 0952-3871 Impact factor: 3.089
Nutrient composition of nutritional supplement and percentage of recommended intakes for Filipino children aged 4–6 years
| Nutrients | Nutritional supplement (450 mL) | Percentage of recommended intakes for Filipino children aged 4–6 years (Barba & Cabrera |
|---|---|---|
| Energy, kcal | 450 | 32 |
| Protein (g) | 13.5 | 48 |
| Vitamin A (μg) | 270 | 35.5 |
| Vitamin C (mg) | 45 | 150 |
| Vitamin B1 (mg) | 1.4 | 230 |
| Vitamin B2 (mg) | 0.9 | 150 |
| Niacin (mg) | 6.8 | 97.1 |
| Vitamin B6 (mg) | 1.2 | 200 |
| Vitamin B12 (μg) | 1.4 | 120 |
| Vitamin D (μg) | 9.0 | 180 |
| Vitamin E (mg) | 7.2 | 144 |
| Folate (μg) | 112.5 | 56 |
| Calcium (mg) | 432 | 78.5 |
| Iron (mg) | 6.3 | 70 |
| Iodine (μg) | 43.7 | 49 |
| Magnesium (mg) | 89.1 | 117 |
| Phosphorus (mg) | 373.5 | 75 |
| Zinc (mg) | 3.0 | 56 |
| Selenium (μg) | 14.4 | 65 |
| Manganese (mg) | 0.7 | 47 |
| Lactobacillus acidophilus (cfu) | 3.9 × 107 | |
|
| 2.45 × 106 | |
| Fructo‐oligosaccharides (g) | 1.98 |
Baseline characteristics of children participated in the present study
| Baseline characteristics | Study group ( |
|
|---|---|---|
| Age (months) | 41.2 (3.59) | |
| Sex | ||
| Male | 99 (49.7) | |
| Maternal age (years) | 30.0 (6.19) | |
| Maternal education level | ||
| College/University or Higher | 84 (42.2) | |
| High School | 114 (57.3) | |
| Secondary School | 0 | |
| Primary School | 1 (0.5) | |
| Weight (kg) | 12.4 (0.98) | |
| Male | 12.7 (0.90) | <0.0001 |
| Female | 12.2 (0.98) | |
| Height (cm) | 93.3 (3.94) | |
| Male | 93.7 (4.06) | 0.1049 |
| Female | 92.8 (3.79) | |
| Weight‐for‐height percentiles | 15.9 (7.29) | |
| Male | 17.0 (7.64) | 0.0228 |
| Female | 14.8 (6.79) | |
| Weight‐for‐age percentiles | 8.9 (8.54) | |
| Male | 9.8 (8.60) | 0.0712 |
| Female | 8.1 (8.46) | |
| Height‐for‐age percentiles | 14.2 (17.0) | |
| Male | 15.3 (18.5) | 0.7083 |
| Female | 13.1 (15.4) | |
Data are presented as the means (SD), except for sex, which is presented as a percentage.
P‐value is from a t‐test.
P‐value is from the Mann–Whitney U‐test.
Figure 1Mean energy intake at baseline and each post‐baseline visit. P < 0.0001 for each post‐baseline visit compared to baseline. The P‐value is from a signed rank test when controlling for the total number of seven comparisons using stepdown Bonferroni adjustment.
Figure 2Line graphs of mean change in weight (kg) (a) and height (cm) (b) from baseline to each post‐baseline visit. Data points represent mean values; error bars represent 95% confidence intervals of the mean. P < 0.0001 for all post‐baseline visits compared to baseline; P‐value is from a paired t‐test.
Figure 3Line graphs of mean change in weight‐for‐height (a) and weight‐for‐age (b) percentiles from baseline to each post‐baseline visit. Data points represent mean values; error bars represent 95% confidence intervals of the mean. P < 0.0001 for all post‐baseline visits compared to baseline; P‐value is from a signed rank test using stepdown Bonferroni adjustment controlling for all pairwise comparisons for changes from baseline.
Figure 4Line graphs of mean change in height‐for‐age from baseline to each post‐baseline visit. Data points represent mean values; error bars represent 95% confidence intervals of the mean. P < 0.05 from week 16 onwards compared to baseline; P‐value is from a signed rank test using stepdown Bonferroni adjustment controlling for all pairwise comparisons for changes from baseline.
Figure 5Mean changes in weight‐for‐height and height‐for‐age Z‐scores from baseline to each post‐baseline time point.
Figure 6Weight‐for‐age Z‐scores distribution curves at baseline and week 48.
Figure 7Height‐for‐age Z‐scores distribution curves at baseline and week 48.
Figure 8Mean number of sick days at an 8‐week interval over 48‐week period. P < 0.0001 for each post‐week 8 visit; P‐value is from a signed rank test using stepdown Bonferroni adjustment controlling for all pairwise comparisons versus week 8.
Figure 9Physical activity and appetite scores at baseline and each follow‐up visit. P < 0.0001 for all post‐baseline visits when compared with baseline; P‐value is from a signed rank test using stepdown Bonferroni adjustment controlling for all pairwise comparisons versus baseline.
Relationship between weight for height percentile and sociodemographic factors over time
| Effect | Least squares mean | Standard error |
|
|---|---|---|---|
| Baseline nutritional status | |||
| Mildly wasting (WHP < 15) | 19.75 | 0.91 | <0.0001 |
| Normal (WHP ≥ 15) | 35.83 | 0.85 | |
| Weeks | |||
| 4 | 25.68 | 1.40 | 0.5812 |
| 8 | 28.13 | 1.40 | |
| 16 | 29.06 | 1.40 | |
| 24 | 28.54 | 1.40 | |
| 32 | 26.89 | 1.40 | |
| 40 | 28.43 | 1.40 | |
| 48 | 27.78 | 1.40 | |
| Sex | |||
| Female | 26.07 | 0.88 | 0.0006 |
| Male | 29.51 | 0.87 | |
| Baseline age (months) | 0.1670 | ||
| Study site | |||
| Asian Hospital and Medical Center | 28.93 | 0.55 | 0.1221 |
| The Medical City | 26.65 | 1.35 | |
| Highest parental education | |||
| High school | 25.91 | 0.88 | 0.0002 |
| College/University or Higher | 29.66 | 0.88 | |
| Compliance with ONS consumption | |||
| Overall percentage of ONS consumed | 0.0021 | ||
P‐value is from repeated measures ancova. ons, oral nutritional supplementation; whp, weight‐for‐height percentile.
Relationship between height for age and sociodemographic factors over time
| Effect | Least squares mean | Standard error |
|
|---|---|---|---|
| Baseline nutritional status | |||
| Mildly wasting (WHP < 15) | 4.65 | 0.54 | <0.0001 |
| Normal (WHP ≥ 15) | 32.08 | 0.68 | |
| Weeks | |||
| 4 | 16.61 | 0.95 | 0.1473 |
| 8 | 17.23 | 0.95 | |
| 16 | 18.03 | 0.95 | |
| 24 | 18.75 | 0.95 | |
| 32 | 19.19 | 0.95 | |
| 40 | 19.36 | 0.95 | |
| 48 | 19.39 | 0.95 | |
| Sex | |||
| Female | 16.95 | 0.61 | <0.0001 |
| Male | 19.78 | 0.60 | |
| Baseline age (months) | 0.1187 | ||
| Study site | |||
| Asian Hospital and Medical Center | 20.76 | 0.38 | <0.0001 |
| The Medical City | 16.0 | 0.92 | |
| Highest parental education | |||
| High school | 17.28 | 0.61 | 0.0015 |
| College/University or Higher | 19.45 | 0.60 | |
| Compliance with ONS consumption | |||
| Overall percentage of ONS consumed | 0.9240 | ||
P‐value is from repeated measures ancova. ons, oral nutritional supplementation; whp, weight‐for‐height percentile.